Go Pro
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel Free CNSL Stock Alerts

Cambridge Nutritional Sciences (CNSL) Competitors

GBX 1.66 -0.06 (-3.50%)
As of 09:56 AM Eastern
Compare

CNSL vs. CEL, BCE, OTT, FOX, and CZN

Should you buy Cambridge Nutritional Sciences stock or one of its competitors? MarketBeat compares Cambridge Nutritional Sciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cambridge Nutritional Sciences include Celadon Pharmaceuticals (CEL), Beacon Energy (BCE), Oxford Technology 3 Venture Capital Trust (OTT), Fox Marble (FOX), and Curzon Energy (CZN). These companies are all part of the "communication" industry.

How does Cambridge Nutritional Sciences compare to Celadon Pharmaceuticals?

Cambridge Nutritional Sciences (LON:CNSL) and Celadon Pharmaceuticals (LON:CEL) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, valuation, risk, dividends, analyst recommendations and institutional ownership.

Cambridge Nutritional Sciences has a net margin of 16.94% compared to Celadon Pharmaceuticals' net margin of -9,520.00%. Cambridge Nutritional Sciences' return on equity of 12.15% beat Celadon Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Cambridge Nutritional Sciences16.94% 12.15% -2.36%
Celadon Pharmaceuticals -9,520.00%-131.82%-34.40%

Cambridge Nutritional Sciences has a beta of 1.93, indicating that its stock price is 93% more volatile than the broader market. Comparatively, Celadon Pharmaceuticals has a beta of -0.26, indicating that its stock price is 126% less volatile than the broader market.

In the previous week, Cambridge Nutritional Sciences' average media sentiment score of 0.00 equaled Celadon Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Cambridge Nutritional Sciences Neutral
Celadon Pharmaceuticals Neutral

1.6% of Cambridge Nutritional Sciences shares are held by institutional investors. Comparatively, 10.7% of Celadon Pharmaceuticals shares are held by institutional investors. 7.8% of Cambridge Nutritional Sciences shares are held by company insiders. Comparatively, 65.1% of Celadon Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Cambridge Nutritional Sciences has higher revenue and earnings than Celadon Pharmaceuticals. Celadon Pharmaceuticals is trading at a lower price-to-earnings ratio than Cambridge Nutritional Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cambridge Nutritional Sciences£8.06M0.49-£3.03M£0.602.76
Celadon Pharmaceuticals£123.38K66.61-£4.97M-£7.98N/A

Summary

Cambridge Nutritional Sciences beats Celadon Pharmaceuticals on 8 of the 11 factors compared between the two stocks.

How does Cambridge Nutritional Sciences compare to Beacon Energy?

Cambridge Nutritional Sciences (LON:CNSL) and Beacon Energy (LON:BCE) are both small-cap communication companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, media sentiment, institutional ownership, dividends, valuation and risk.

Beacon Energy has lower revenue, but higher earnings than Cambridge Nutritional Sciences. Beacon Energy is trading at a lower price-to-earnings ratio than Cambridge Nutritional Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cambridge Nutritional Sciences£8.06M0.49-£3.03M£0.602.76
Beacon EnergyN/AN/A-£1.58M-£5.65N/A

Cambridge Nutritional Sciences has a net margin of 16.94% compared to Beacon Energy's net margin of 0.00%. Cambridge Nutritional Sciences' return on equity of 12.15% beat Beacon Energy's return on equity.

Company Net Margins Return on Equity Return on Assets
Cambridge Nutritional Sciences16.94% 12.15% -2.36%
Beacon Energy N/A -196.88%-6.61%

In the previous week, Beacon Energy had 1 more articles in the media than Cambridge Nutritional Sciences. MarketBeat recorded 1 mentions for Beacon Energy and 0 mentions for Cambridge Nutritional Sciences. Beacon Energy's average media sentiment score of 0.80 beat Cambridge Nutritional Sciences' score of 0.00 indicating that Beacon Energy is being referred to more favorably in the news media.

Company Overall Sentiment
Cambridge Nutritional Sciences Neutral
Beacon Energy Positive

Cambridge Nutritional Sciences has a beta of 1.93, indicating that its share price is 93% more volatile than the broader market. Comparatively, Beacon Energy has a beta of -0.3, indicating that its share price is 130% less volatile than the broader market.

1.6% of Cambridge Nutritional Sciences shares are held by institutional investors. Comparatively, 5.0% of Beacon Energy shares are held by institutional investors. 7.8% of Cambridge Nutritional Sciences shares are held by company insiders. Comparatively, 5.9% of Beacon Energy shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Cambridge Nutritional Sciences beats Beacon Energy on 8 of the 12 factors compared between the two stocks.

How does Cambridge Nutritional Sciences compare to Oxford Technology 3 Venture Capital Trust?

Oxford Technology 3 Venture Capital Trust (LON:OTT) and Cambridge Nutritional Sciences (LON:CNSL) are both small-cap communication companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.

Oxford Technology 3 Venture Capital Trust has higher earnings, but lower revenue than Cambridge Nutritional Sciences. Oxford Technology 3 Venture Capital Trust is trading at a lower price-to-earnings ratio than Cambridge Nutritional Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oxford Technology 3 Venture Capital Trust-£85K0.00N/A-£2.70N/A
Cambridge Nutritional Sciences£8.06M0.49-£3.03M£0.602.76

1.6% of Cambridge Nutritional Sciences shares are owned by institutional investors. 7.8% of Cambridge Nutritional Sciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Cambridge Nutritional Sciences has a net margin of 16.94% compared to Oxford Technology 3 Venture Capital Trust's net margin of 0.00%. Cambridge Nutritional Sciences' return on equity of 12.15% beat Oxford Technology 3 Venture Capital Trust's return on equity.

Company Net Margins Return on Equity Return on Assets
Oxford Technology 3 Venture Capital TrustN/A N/A N/A
Cambridge Nutritional Sciences 16.94%12.15%-2.36%

In the previous week, Oxford Technology 3 Venture Capital Trust's average media sentiment score of 0.00 equaled Cambridge Nutritional Sciences'average media sentiment score.

Company Overall Sentiment
Oxford Technology 3 Venture Capital Trust Neutral
Cambridge Nutritional Sciences Neutral

Summary

Cambridge Nutritional Sciences beats Oxford Technology 3 Venture Capital Trust on 7 of the 8 factors compared between the two stocks.

How does Cambridge Nutritional Sciences compare to Fox Marble?

Cambridge Nutritional Sciences (LON:CNSL) and Fox Marble (LON:FOX) are both small-cap communication companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, earnings, dividends and analyst recommendations.

Fox Marble has lower revenue, but higher earnings than Cambridge Nutritional Sciences. Fox Marble is trading at a lower price-to-earnings ratio than Cambridge Nutritional Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cambridge Nutritional Sciences£8.06M0.49-£3.03M£0.602.76
Fox MarbleN/AN/A-£2.04M-£0.03N/A

In the previous week, Cambridge Nutritional Sciences' average media sentiment score of 0.00 equaled Fox Marble'saverage media sentiment score.

Company Overall Sentiment
Cambridge Nutritional Sciences Neutral
Fox Marble Neutral

Cambridge Nutritional Sciences has a net margin of 16.94% compared to Fox Marble's net margin of -282.21%. Cambridge Nutritional Sciences' return on equity of 12.15% beat Fox Marble's return on equity.

Company Net Margins Return on Equity Return on Assets
Cambridge Nutritional Sciences16.94% 12.15% -2.36%
Fox Marble -282.21%-38.15%-10.32%

Cambridge Nutritional Sciences has a beta of 1.93, suggesting that its stock price is 93% more volatile than the broader market. Comparatively, Fox Marble has a beta of 0.54, suggesting that its stock price is 46% less volatile than the broader market.

1.6% of Cambridge Nutritional Sciences shares are owned by institutional investors. Comparatively, 2.2% of Fox Marble shares are owned by institutional investors. 7.8% of Cambridge Nutritional Sciences shares are owned by company insiders. Comparatively, 19.4% of Fox Marble shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Cambridge Nutritional Sciences beats Fox Marble on 7 of the 10 factors compared between the two stocks.

How does Cambridge Nutritional Sciences compare to Curzon Energy?

Cambridge Nutritional Sciences (LON:CNSL) and Curzon Energy (LON:CZN) are both small-cap communication companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability, media sentiment and risk.

1.6% of Cambridge Nutritional Sciences shares are owned by institutional investors. 7.8% of Cambridge Nutritional Sciences shares are owned by company insiders. Comparatively, 5.3% of Curzon Energy shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Cambridge Nutritional Sciences has a beta of 1.93, suggesting that its stock price is 93% more volatile than the broader market. Comparatively, Curzon Energy has a beta of 0.55, suggesting that its stock price is 45% less volatile than the broader market.

Curzon Energy has lower revenue, but higher earnings than Cambridge Nutritional Sciences. Curzon Energy is trading at a lower price-to-earnings ratio than Cambridge Nutritional Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cambridge Nutritional Sciences£8.06M0.49-£3.03M£0.602.76
Curzon EnergyN/AN/AN/A-£0.01N/A

In the previous week, Cambridge Nutritional Sciences' average media sentiment score of 0.00 equaled Curzon Energy'saverage media sentiment score.

Company Overall Sentiment
Cambridge Nutritional Sciences Neutral
Curzon Energy Neutral

Cambridge Nutritional Sciences has a net margin of 16.94% compared to Curzon Energy's net margin of 0.00%. Cambridge Nutritional Sciences' return on equity of 12.15% beat Curzon Energy's return on equity.

Company Net Margins Return on Equity Return on Assets
Cambridge Nutritional Sciences16.94% 12.15% -2.36%
Curzon Energy N/A N/A -272.65%

Summary

Cambridge Nutritional Sciences beats Curzon Energy on 9 of the 9 factors compared between the two stocks.

Get Cambridge Nutritional Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for CNSL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNSL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CNSL vs. The Competition

Export
MetricCambridge Nutritional SciencesMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£4.16M£3.02B£7.06B£2.84B
Dividend YieldN/A1.91%2.68%6.17%
P/E Ratio2.7617.4927.15368.18
Price / Sales0.49107.81526.8984,612.72
Price / CashN/A146.5429.2227.87
Price / Book0.412.5410.757.49
Net Income-£3.03M£99.80M£3.58B£5.89B
7 Day Performance-2.65%0.99%-2.10%-0.48%
1 Month Performance-4.00%3.65%3.32%-1.00%
1 Year Performance-57.99%-5.72%28.17%61.74%

Cambridge Nutritional Sciences Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CNSL
Cambridge Nutritional Sciences
N/AGBX 1.66
-3.5%		N/A-56.5%£4.16M£8.06M2.763,200
CEL
Celadon Pharmaceuticals
N/AGBX 13.40
flat		N/AN/A£8.22M£123.38KN/A2,780
BCE
Beacon Energy
N/AGBX 3
-10.4%		N/AN/A£3.74MN/AN/A44,600
OTT
Oxford Technology 3 Venture Capital Trust
N/AN/AN/AN/A£2.13M-£85KN/A203
FOX
Fox Marble
N/AGBX 0.02
-4.3%		N/A-45.0%£809KN/AN/A10,600

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:CNSL) was last updated on 7/13/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel